531 related articles for article (PubMed ID: 28320424)
41. ApoE4 makes microglia trem
Heneka MT
Neuron; 2023 Jan; 111(2):142-144. PubMed ID: 36657395
[TBL] [Abstract][Full Text] [Related]
42. RNA-sequencing reveals transcriptional up-regulation of Trem2 in response to bexarotene treatment.
Lefterov I; Schug J; Mounier A; Nam KN; Fitz NF; Koldamova R
Neurobiol Dis; 2015 Oct; 82():132-140. PubMed ID: 26071899
[TBL] [Abstract][Full Text] [Related]
43. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice.
Jiang T; Zhang YD; Chen Q; Gao Q; Zhu XC; Zhou JS; Shi JQ; Lu H; Tan L; Yu JT
Neuropharmacology; 2016 Jun; 105():196-206. PubMed ID: 26802771
[TBL] [Abstract][Full Text] [Related]
44. TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy.
Leyns CEG; Ulrich JD; Finn MB; Stewart FR; Koscal LJ; Remolina Serrano J; Robinson GO; Anderson E; Colonna M; Holtzman DM
Proc Natl Acad Sci U S A; 2017 Oct; 114(43):11524-11529. PubMed ID: 29073081
[TBL] [Abstract][Full Text] [Related]
45. The role of TREM2 in Alzheimer's disease and other neurodegenerative disorders.
Carmona S; Zahs K; Wu E; Dakin K; Bras J; Guerreiro R
Lancet Neurol; 2018 Aug; 17(8):721-730. PubMed ID: 30033062
[TBL] [Abstract][Full Text] [Related]
46. Alzheimer's disease-associated TREM2 variants exhibit either decreased or increased ligand-dependent activation.
Song W; Hooli B; Mullin K; Jin SC; Cella M; Ulland TK; Wang Y; Tanzi RE; Colonna M
Alzheimers Dement; 2017 Apr; 13(4):381-387. PubMed ID: 27520774
[TBL] [Abstract][Full Text] [Related]
47. TREM2 variants in Alzheimer's disease.
Guerreiro R; Wojtas A; Bras J; Carrasquillo M; Rogaeva E; Majounie E; Cruchaga C; Sassi C; Kauwe JS; Younkin S; Hazrati L; Collinge J; Pocock J; Lashley T; Williams J; Lambert JC; Amouyel P; Goate A; Rademakers R; Morgan K; Powell J; St George-Hyslop P; Singleton A; Hardy J;
N Engl J Med; 2013 Jan; 368(2):117-27. PubMed ID: 23150934
[TBL] [Abstract][Full Text] [Related]
48. TREM2 Attenuates Aβ1-42-Mediated Neuroinflammation in BV-2 Cells by Downregulating TLR Signaling.
Long H; Zhong G; Wang C; Zhang J; Zhang Y; Luo J; Shi S
Neurochem Res; 2019 Aug; 44(8):1830-1839. PubMed ID: 31134514
[TBL] [Abstract][Full Text] [Related]
49. The triggering receptor expressed on myeloid cells 2-apolipoprotein E signaling pathway in diseases.
Lyu S; Lan Z; Li C
Chin Med J (Engl); 2023 Jun; 136(11):1291-1299. PubMed ID: 37130227
[TBL] [Abstract][Full Text] [Related]
50. Pinpointing Brain TREM2 Levels in Two Mouse Models of Alzheimer's Disease.
Meier SR; Sehlin D; Hultqvist G; Syvänen S
Mol Imaging Biol; 2021 Oct; 23(5):665-675. PubMed ID: 33620643
[TBL] [Abstract][Full Text] [Related]
51. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques.
Wang Y; Ulland TK; Ulrich JD; Song W; Tzaferis JA; Hole JT; Yuan P; Mahan TE; Shi Y; Gilfillan S; Cella M; Grutzendler J; DeMattos RB; Cirrito JR; Holtzman DM; Colonna M
J Exp Med; 2016 May; 213(5):667-75. PubMed ID: 27091843
[TBL] [Abstract][Full Text] [Related]
52. TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models.
Jay TR; Miller CM; Cheng PJ; Graham LC; Bemiller S; Broihier ML; Xu G; Margevicius D; Karlo JC; Sousa GL; Cotleur AC; Butovsky O; Bekris L; Staugaitis SM; Leverenz JB; Pimplikar SW; Landreth GE; Howell GR; Ransohoff RM; Lamb BT
J Exp Med; 2015 Mar; 212(3):287-95. PubMed ID: 25732305
[TBL] [Abstract][Full Text] [Related]
53. Peripheral TREM2 mRNA levels in early and late-onset Alzheimer disease's patients.
Guven G; Bilgic B; Samanci B; Gurvit H; Hanagasi H; Donmez C; Aslan R; Lohmann E; Erginel-Unaltuna N
Mol Biol Rep; 2020 Aug; 47(8):5903-5909. PubMed ID: 32681391
[TBL] [Abstract][Full Text] [Related]
54. A reporter cell system for the triggering receptor expressed on myeloid cells 2 reveals differential effects of disease-associated variants on receptor signaling and activation by antibodies against the stalk region.
Ibach M; Mathews M; Linnartz-Gerlach B; Theil S; Kumar S; Feederle R; Brüstle O; Neumann H; Walter J
Glia; 2021 May; 69(5):1126-1139. PubMed ID: 33314333
[TBL] [Abstract][Full Text] [Related]
55. TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model.
Wang Y; Cella M; Mallinson K; Ulrich JD; Young KL; Robinette ML; Gilfillan S; Krishnan GM; Sudhakar S; Zinselmeyer BH; Holtzman DM; Cirrito JR; Colonna M
Cell; 2015 Mar; 160(6):1061-71. PubMed ID: 25728668
[TBL] [Abstract][Full Text] [Related]
56. TREM2 splice isoforms generate soluble TREM2 species that disrupt long-term potentiation.
Moutinho M; Coronel I; Tsai AP; Di Prisco GV; Pennington T; Atwood BK; Puntambekar SS; Smith DC; Martinez P; Han S; Lee Y; Lasagna-Reeves CA; Lamb BT; Bissel SJ; Nho K; Landreth GE
Genome Med; 2023 Feb; 15(1):11. PubMed ID: 36805764
[TBL] [Abstract][Full Text] [Related]
57. An apolipoprotein E-based therapeutic improves outcome and reduces Alzheimer's disease pathology following closed head injury: evidence of pharmacogenomic interaction.
Wang H; Durham L; Dawson H; Song P; Warner DS; Sullivan PM; Vitek MP; Laskowitz DT
Neuroscience; 2007 Feb; 144(4):1324-33. PubMed ID: 17187933
[TBL] [Abstract][Full Text] [Related]
58. Neuroprotective Effect of TREM-2 in Aging and Alzheimer's Disease Model.
Raha AA; Henderson JW; Stott SR; Vuono R; Foscarin S; Friedland RP; Zaman SH; Raha-Chowdhury R
J Alzheimers Dis; 2017; 55(1):199-217. PubMed ID: 27662313
[TBL] [Abstract][Full Text] [Related]
59. An Alzheimer-associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function.
Schlepckow K; Kleinberger G; Fukumori A; Feederle R; Lichtenthaler SF; Steiner H; Haass C
EMBO Mol Med; 2017 Oct; 9(10):1356-1365. PubMed ID: 28855300
[TBL] [Abstract][Full Text] [Related]
60. TREM2 ectodomain and its soluble form in Alzheimer's disease.
Yang J; Fu Z; Zhang X; Xiong M; Meng L; Zhang Z
J Neuroinflammation; 2020 Jul; 17(1):204. PubMed ID: 32635934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
